Lumos Labs, announced today that the FDA has granted 510(k) clearance for LumosityRx, a prescription digital therapeutic for adults with ADHD.

CBT is an evidence-supported treatment for adult ADHD. Evolving trends in CBT have already improved adult ADHD treatment, and ...

A new online tool is designed to help families and clinicians make informed treatment decisions. The most extensive ...

Study Exposes Critical Gap in Long-Term Research In A Nutshell Methylphenidate (Ritalin) leads for all ages. The medication ...

The most comprehensive review to date of ADHD treatments has found that medication for children and adults, and cognitive ...

Adult ADHD has emerged as a significant health concern in the United States, with approximately one-quarter of adults suspecting they may have undiagnosed attention deficit hyperactivity disorder.

On Thursday, the CDC released new data showing that almost 15.5 million U.S. adults are living with ADHD. More than half of those individuals received their diagnosis in adulthood. That includes me.

An NHS trust has announced that it has temporarily ceased accepting new adult ADHD referrals. Berkshire Healthcare said the ...

A woman diagnosed with attention deficit hyperactivity disorder (ADHD) at the age of 48 has said her local trust not ...